191 related articles for article (PubMed ID: 7588209)
21. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone-induced differential desensitization of STAT5, ERK, and Akt phosphorylation.
Ji S; Frank SJ; Messina JL
J Biol Chem; 2002 Aug; 277(32):28384-93. PubMed ID: 12161450
[TBL] [Abstract][Full Text] [Related]
23. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
Goh EL; Zhu T; Leong WY; Lobie PE
Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
25. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b.
Zhou YC; Waxman DJ
J Biol Chem; 1999 Jan; 274(5):2672-81. PubMed ID: 9915797
[TBL] [Abstract][Full Text] [Related]
26. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway.
Ji S; Guan R; Frank SJ; Messina JL
J Biol Chem; 1999 May; 274(19):13434-42. PubMed ID: 10224108
[TBL] [Abstract][Full Text] [Related]
27. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
Stofega MR; Herrington J; Billestrup N; Carter-Su C
Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
29. Differential tyrosine phosphorylation of JAK1, JAK2, and STAT1 by growth hormone and interferon-gamma in IM-9 cells.
Silva CM; Lu H; Weber MJ; Thorner MO
J Biol Chem; 1994 Nov; 269(44):27532-9. PubMed ID: 7525556
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes.
Eriksson H; Ridderstråle M; Tornqvist H
Endocrinology; 1995 Nov; 136(11):5093-101. PubMed ID: 7588246
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor.
Mazurkiewicz-Munoz AM; Argetsinger LS; Kouadio JL; Stensballe A; Jensen ON; Cline JM; Carter-Su C
Mol Cell Biol; 2006 Jun; 26(11):4052-62. PubMed ID: 16705159
[TBL] [Abstract][Full Text] [Related]
32. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.
Argetsinger LS; Campbell GS; Yang X; Witthuhn BA; Silvennoinen O; Ihle JN; Carter-Su C
Cell; 1993 Jul; 74(2):237-44. PubMed ID: 8343952
[TBL] [Abstract][Full Text] [Related]
33. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
Rui L; Gunter DR; Herrington J; Carter-Su C
Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
[TBL] [Abstract][Full Text] [Related]
34. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
35. Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways.
Kilgour E; Gout I; Anderson NG
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):517-22. PubMed ID: 8615823
[TBL] [Abstract][Full Text] [Related]
36. The identification of JAK2 tyrosine kinase as a signaling molecule for growth hormone.
Carter-Su C; Argetsinger LS; Campbell GS; Wang X; Ihle J; Witthuhn B
Proc Soc Exp Biol Med; 1994 Jul; 206(3):210-5. PubMed ID: 7517045
[TBL] [Abstract][Full Text] [Related]
37. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone.
Campbell GS; Meyer DJ; Raz R; Levy DE; Schwartz J; Carter-Su C
J Biol Chem; 1995 Feb; 270(8):3974-9. PubMed ID: 7876144
[TBL] [Abstract][Full Text] [Related]
38. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase.
VanderKuur JA; Wang X; Zhang L; Campbell GS; Allevato G; Billestrup N; Norstedt G; Carter-Su C
J Biol Chem; 1994 Aug; 269(34):21709-17. PubMed ID: 8063815
[TBL] [Abstract][Full Text] [Related]
39. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors.
Gong TW; Meyer DJ; Liao J; Hodge CL; Campbell GS; Wang X; Billestrup N; Carter-Su C; Schwartz J
Endocrinology; 1998 Apr; 139(4):1863-71. PubMed ID: 9528972
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
VanderKuur JA; Wang X; Zhang L; Allevato G; Billestrup N; Carter-Su C
J Biol Chem; 1995 Sep; 270(37):21738-44. PubMed ID: 7545168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
